9th Circ. COVID 'Cure' Case Shows Perks Of Puffery Defense
On March 25, the U.S. Court of Appeals for the Ninth Circuit affirmed the dismissal of securities fraud claims against biopharmaceutical company Sorrento Therapeutics Inc., CEO Henry Ji and Vice President Mark...To view the full article, register now.
Already a subscriber? Click here to view full article